Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models

Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models

Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of glucose-lowering agents widely used for the treatment of type 2 diabetes mellitus. A number of clinical trials in type 2 diabetic patients with different degrees of renal impairment have clearly demonstrated that SGLT2 inhibitors reduc...

Full description

Bibliographic Details
Main Authors: Giovanna Castoldi, Raffaella Carletti, Francesca Barzaghi, Michela Meani, Giovanni Zatti, Gianluca Perseghin, Cira R. T. Di Gioia, Gianpaolo Zerbini
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Pharmaceuticals
Subjects:
SGLT2 inhibitors
non-diabetic kidney disease
experimental models of non-diabetic nephropathies
Online Access:https://www.mdpi.com/1424-8247/17/3/362

Internet

https://www.mdpi.com/1424-8247/17/3/362

Similar Items